Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lipedema pain mystery: could your metabolism be the key?

NCT ID NCT07468097

Knowledge-focused Sponsor: Marmara University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how metabolic markers like insulin resistance and body measurements relate to pain and central sensitization in women with lipedema. Researchers will assess 59 women using questionnaires and physical measurements. The goal is to better understand these connections, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could reveal links between metabolic health and pain in lipedema, pointing toward future management strategies.
What could go wrong
This is a small, observational study with no intervention, so it cannot prove cause and effect. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 59 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged 18 years or older with a diagnosis of lipedema who have undergone laboratory testing in which metabolic markers were evaluated within the past three months.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being female and aged 18 years or older * Having chronic pain persisting for at least 3 months * Having sufficient cognitive ability to understand and respond to the assessment scales used in the study * Voluntarily agreeing to participate in the study and providing written informed consent Exclusion Criteria: * Presence of a history of malignancy, active infection, inflammatory rheumatic disease, or severe systemic disease * History of known neurological disorders (e.g., stroke, multiple sclerosis, epilepsy) * Diagnosis of severe psychiatric disorders (e.g., psychotic disorders, bipolar disorder) * Pregnancy or breastfeeding * Presence of cognitive impairment or communication difficulties that could affect the study results * Diagnosed diabetes mellitus * Active thyroid disease (uncontrolled hypothyroidism or hyperthyroidism) * Cushing's syndrome or other significant endocrine disorders * Use of antidiabetic medications * Use of lipid-lowering therapy (e.g., statins, fibrates) * Systemic glucocorticoid use within the past 3 months * Use of medications that may significantly affect central pain mechanisms (e.g., high-dose opioids, antipsychotic drugs) * History of major surgery or invasive treatment for pain within the past 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central sensitization are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Lipedema Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Central sensitization Homa-ir Lipedema Pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Marmara University Faculty of Medicine Pendik Training and Research Hospital

    RECRUITING

    Istanbul, Pendik, 34890, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.